STUDIES ON EXPERIMENTAL PNEUMONIA : VII. TREATMENT OF EXPERIMENTAL PNEUMOCOCCUS TYPE I PNEUMONIA IN MONKEYS WITH TYPE
Abstract:
1. In experimental Pneumococcus Type I pneumonia in monkeys the intravenous injection of Type I antipneumococcus serum exercises a specific therapeutic effect, frees the blood promptly and permanently from pneumococci, shortens the course of the disease, and greatly moderates its severity. Of five monkeys inoculated intratracheally with lethal doses of Pneumococcus Type I, all developed pneumonia, and all recovered following the administration of Type I antipneumococcus serum, while the controls died. 2. The earlier the serum is administered the shorter and less severe the pneumonia. Frequent injections are also an important factor in obtaining favorable results. When serum treatment is instituted late in the disease, the injections must usually be continued over a longer period of time in order to achieve success. 3. Normal horse serum exerts no beneficial effect whatever in experimental Pneumococcus Type I pneumonia.
More Related Videos
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction


